ARM Holdings plc Consolidated balance sheet - IFRS 30 September 2012 Unaudited £m

31 December 2011 Audited £m

Assets Current assets: Cash and cash equivalents Short-term deposits Fair value of currency exchange contracts Embedded derivatives Accounts receivable Prepaid expenses and other assets Other debtors (see note 4) Current tax assets Inventories: finished goods Total current assets

104.9 337.4 1.8 98.3 33.6 104.5 8.4 2.1 691.0

26.8 319.1 1.2 119.6 30.7 6.2 2.5 506.1

Non-current assets: Available-for-sale financial assets Long-term deposits Loans and receivables Prepaid expenses and other assets Property, plant and equipment Goodwill Other intangible assets Deferred tax assets Total non-current assets

15.2 141.8 2.1 2.5 32.1 522.6 12.6 60.5 789.4

27.3 83.1 2.0 2.3 18.1 542.5 12.5 105.9 793.7

1,480.4

1,299.8

Liabilities and shareholders’ equity Current liabilities: Accounts payable Fair value of currency exchange contracts Embedded derivatives Accrued and other liabilities (see note 3) Current tax liabilities Obligations under finance leases Borrowings (see note 4) Deferred revenue Total current liabilities

4.4 2.8 62.8 6.0 1.5 99.1 116.0 292.6

8.7 1.5 84.9 26.7 102.2 224.0

Non-current liabilities: Obligations under finance leases Deferred revenue Total non-current liabilities Total liabilities

2.4 20.3 22.7 315.3

14.6 14.6 238.6

Net assets

1,165.1

1,061.2

Capital and reserves attributable to equity holders of the Company Share capital Share premium account Capital reserve Share option reserve Retained earnings Revaluation reserve Cumulative translation adjustment Total equity

0.7 11.4 354.3 61.4 659.0 0.3 78.0 1,165.1

0.7 6.6 351.6 61.4 539.7 0.3 100.9 1,061.2

Total assets

8 of 18

ARM Holdings plc Consolidated income statement – IFRS Quarter Quarter Nine months Nine months ended ended ended ended 30 September 30 September 30 September 30 September 2012 2011 2012 2011 Unaudited Unaudited Unaudited Unaudited £m £m £m £m

144.6

120.2

412.7

354.0

(8.3)

(6.9)

(23.3)

(21.1)

Gross profit

136.3

113.3

389.4

332.9

Research and development Sales and marketing General and administrative Total operating expenses, net

(39.6) (17.6) (27.4) (84.6)

(37.4) (18.0) (17.0) (72.4)

(120.0) (51.7) (66.3) (238.0)

(122.4) (52.4) (56.2) (231.0)

Profit from operations

51.7

40.9

151.4

101.9

Investment income, net

3.6

2.1

10.2

5.4

55.3 (14.0)

43.0 (11.6)

161.6 (43.3)

107.3 (27.7)

Profit for the period

41.3

31.4

118.3

79.6

Earnings per share Basic and diluted earnings

41.3

31.4

118.3

79.6

1,378.1 17.8 1,395.9

1,348.1 27.9 1,376.0

1,373.4 20.2 1,393.6

1,343.1 31.1 1,374.2

3.0 3.0

2.3 2.3

8.6 8.5

5.9 5.8

14.3

10.7

41.1

27.1

Revenues Cost of revenues

Profit before tax Tax

Number of shares (millions) Basic weighted average number of shares Effect of dilutive securities: Share options and awards Diluted weighted average number of shares Basic EPS (pence) Diluted EPS (pence) Diluted earnings per ADS (cents)

All activities relate to continuing operations. All of the profit for the period is attributable to the equity shareholders of the parent.

9 of 18

ARM Holdings plc Consolidated statement of comprehensive income - IFRS Quarter ended 30 September 2012 Unaudited £m

Quarter ended 30 September 2011 Unaudited £m

Nine months ended 30 September 2012 Unaudited £m

Nine months ended 30 September 2011 Unaudited £m

41.3

31.4

118.3

79.6

(1.0) (16.7) (17.7) 23.6

13.6 13.6 45.0

(22.9) (22.9) 95.4

0.6 0.6 80.2

Profit for the period Other comprehensive income: Unrealised holding loss on available-for-sale investments (net of tax of £nil) Currency translation adjustment Other comprehensive income /(loss) for the period Total comprehensive income for the period

10 of 18

ARM Holdings plc Consolidated statement of changes in shareholders’ equity – IFRS

At 1 January 2011 (audited) Profit for the period Other comprehensive income: Currency translation adjustment Total comprehensive income for the nine month period Shares issued on exercise of share options and awards Dividends Credit in respect of employee share schemes Movement on tax arising on share options and awards Proceeds from sale of own shares At 30 September 2011 (unaudited)

At 1 January 2012 (audited) Profit for the period Other comprehensive income: Currency translation adjustment Total comprehensive income/(loss) for nine month period Shares issued on exercise of share options and awards Dividends Credit in respect of employee share schemes Movement on tax arising on share options and awards Refund of costs related to share issue At 30 September 2012 (unaudited)

Share capital £m

Share premium account £m

Capital reserve £m

Share option reserve £m

Retained earnings £m

Reval-uation reserve £m

Cumulative translation adjustment £m

Total £m

0.7 −

− −

351.6 −

61.4 −

381.4 79.6

− −

99.8 −

894.9 79.6

− − − − − − − − 0.7

− − 5.8 − − − − 5.8 5.8

− − − − − − − − 351.6

− − − − − − − − 61.4

− 79.6 − (23.4) 29.7 38.2 1.9 46.4 507.4

− − − − − − − − −

0.6 0.6 − − − − − − 100.4

0.6 80.2 5.8 (23.4) 29.7 38.2 1.9 52.2 1,027.3

0.7 −

6.6 −

351.6 −

61.4 −

539.7 118.3

0.3 −

100.9 −

1,061.2 118.3

− − − − − − − − 0.7

− − 4.8 − − − − 4.8 11.4

− − − − − − 2.7 2.7 354.3

− − − − − − − − 61.4

− 118.3 − (28.8) 26.5 3.3 − 1.0 659.0

− − − − − − − − 0.3

(22.9) (22.9) − − − − − − 78.0

(22.9) 95.4 4.8 (28.8) 26.5 3.3 2.7 8.5 1,165.1

11 of 18

Notes to the Financial Information (1) Basis of preparation The financial information prepared in accordance with the Group's IFRS accounting policies (consistent with those stated in the financial statements for the year ended 31 December 2011 with the exception of finance leases as described below) comprises the consolidated balance sheets at 30 September 2012 and 31 December 2011, consolidated income statements and consolidated statements of comprehensive income for the three months and nine months ended 30 September 2012 and 2011, and consolidated statements of changes in shareholders’ equity for the nine months ended 30 September 2012 and 2011, together with related notes. This condensed set of consolidated interim financial information for the nine months ended 30 September 2012 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority. This financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2011, which have been prepared in accordance with IFRSs as adopted by the European Union. Finance leases Leases of property, plant and equipment, where the Group has substantially all the risks and rewards of ownership, are classified as finance leases. Finance leases are capitalised at the lease’s commencement at the lower of the fair value of the leased property and the present value of the minimum lease payments. Each lease payment is allocated between the liability and finance charges. The corresponding rental obligations, net of finance charges, are included in liabilities. The interest element of the finance cost is charged to the income statement over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The property, plant and equipment acquired under finance leases is depreciated over the shorter of the useful life of the asset and the lease term.

(2) Share-based payment costs and acquisition-related expenses Included within the consolidated income statement for the quarter ended 30 September 2012 are total share-based payment costs (including related payroll taxes) of £11.1 million (2011: £11.7 million), allocated £0.5 million (2011: £0.8 million) in cost of revenues, £6.1 million (2011: £7.0 million) in research and development expenses, £1.8 million (2011: £2.3 million) in sales and marketing expenses and £2.7 million (2011: £1.6 million) in general and administrative expenses. Included within the consolidated income statement for the nine months ended 30 September 2012 are total share-based payment costs (including related payroll taxes) of £29.2 million (2011: £43.6 million), allocated £1.4 million (2011: £2.5 million) in cost of revenues, £17.6 million (2011: £26.3 million) in research and development expenses, £5.1 million (2011: £8.6 million) in sales and marketing expenses and £5.1 million (2011: £6.2 million) in general and administrative expenses. Included within operating expenses for the quarter ended 30 September 2012 are total acquisition-related charges of £1.0 million (including retention bonuses on acquisitions amounting to £0.7 million) (2011: £0.3 million), allocated £0.7 million (2011: £nil) in research and development expenses, £0.1 million (2011: £0.1 million) in sales and marketing expenses and £0.2 million (2011: £0.2 million) in general and administrative expenses. Included within operating expenses for the nine months ended 30 September 2012 are total acquisition-related charges of £4.3 million (including retention bonuses on acquisitions amounting to £3.5 million) (2011: £0.8 million), allocated £3.5 million (2011: £nil) in research and development expenses, £0.3 million (2011: £0.3 million) in sales and marketing expenses and £0.5 million (2011: £0.5 million) in general and administrative expenses.

(3) Accrued and other liabilities Included within accrued and other liabilities at 30 September 2012 are £11.4 million (31 December 2011: £22.6 million) relating to the provision for payroll taxes on share awards, and £12.2 million (31 December 2011: £23.7 million) relating to employee bonus and sales commission provisions.

(4) Other debtors and borrowings ARM regularly evaluates strategic opportunities and, in pursuance of one such opportunity, had conditionally committed £104.5 million as of 30 September 2012. This amount, which is classified as Other Debtors, represents the entire investment being contemplated and in the event a transaction is not completed, the amount will be returned to ARM. To avoid early termination of term deposits, £99.1 million of the amount was financed through a short term bank facility.

12 of 18

(5) Non-GAAP measures The following non-GAAP measures, including reconciliations to the IFRS measures, have been used in this earnings release. These measures have been presented as they allow a clearer comparison of operating results that exclude acquisition-related charges, sharebased payment costs, profit or loss on disposal and impairment of available-for-sale investments, and Linaro-related charges. Full reconciliations of Q3 2012, Q3 2011, 9M 2012 and 9M 2011, are shown in notes 5.13 to 5.16. All figures in £millions unless otherwise stated. Summary normalised figures

Q3 2012

Q3 2011

Q2 2012

9M 2012

9M 2011

144.6 227.9

120.2 192.3

135.5 213.0

412.7 650.3

354.0 568.0

94.6% 72.3 64.5 44.6%

94.9% 60.5 53.6 44.6%

95.1% 66.0 62.9 46.4%

94.7% 204.4 186.4 45.2%

94.7% 180.1 155.3 43.9%

Profit before tax Earnings per share (diluted)

68.1 3.71p

55.7 3.05p

66.5 3.58p

196.6 10.63p

160.7 8.75p

Net cash Cash generation

477.9 88.0

397.2 43.7

495.9 46.9

477.9 193.3

397.2 152.3

(5.1) Q3 2012

(5.2) Q3 2011

(5.3) Q2 2012

(5.4) 9M 2012

(5.5) 9M 2011

144.6 1.58 227.9

120.2 1.60 192.3

135.5 1.57 213.0

412.7 1.58 650.3

354.0 1.60 568.0

Revenues Revenues ($m) Gross margin Operating expenses Profit from operations Operating margin

Revenues (£m) ARM’s effective exchange rate ($/£) Revenues ($m)

(5.6) 30 September 2012

(5.7) 31 December 2011

Cash and cash equivalents Short-term deposits Long-term deposits Less: Interest accrued Less: Borrowings

104.9 337.4 141.8 (7.1) (99.1)

26.8 319.1 83.1 (5.0) -

Total net cash

477.9

424.0

Normalised cash at end of period (as above) Less: Normalised cash at beginning of period Add back: Cash outflow from conditional investment (see note 4) Add back: Cash (inflow)/outflow from investments and acquisitions (net of cash acquired) Add back: Cash outflow from acquisition costs Add back: Cash outflow from payment of dividends Add back: Cash outflow from share-based payroll taxes Add back: Cash outflow from payments related to Linaro Less: Cash inflow from exercise of share options Normalised cash generation

(5.8) Q3 2012

(5.9) Q3 2011

(5.10) Q2 2012

(5.11) 9M 2012

(5.12) 9M 2011

477.9 (495.9)

397.2 (353.8)

495.9 (469.2)

477.9 (424.0)

397.2 (290.1)

104.5

-

-

104.5

-

0.1 2.7 0.3 0.9 (2.5) 88.0

2.2 0.4 0.2 0.8 (3.3) 43.7

(10.0) 0.3 28.8 0.4 0.8 (0.1) 46.9

(9.0) 3.3 28.8 14.0 2.6 (4.8) 193.3

11.5 3.2 23.4 12.2 2.6 (7.7) 152.3

13 of 18

(5.13) Normalised income statement for Q3 2012

Normalised

Share-based payments

Normalised incl sharebased payments

Intangible amortisation

Acquisition -related charges

IFRS

£m

£m

£m

£m

£m

£m

144.6

-

144.6

-

-

144.6

(7.8)

(0.5)

(8.3)

-

-

(8.3)

Gross profit

136.8

(0.5)

136.3

-

-

136.3

Research and development Sales and marketing General and administrative Total operating expenses

(32.2) (15.6) (24.5) (72.3)

(6.1) (1.8) (2.7) (10.6)

(38.3) (17.4) (27.2) (82.9)

(0.6) (0.1) (0.7)

(0.7) (0.1) (0.2) (1.0)

(39.6) (17.6) (27.4) (84.6)

Profit from operations

64.5

(11.1)

53.4

(0.7)

(1.0)

51.7

Investment income, net

3.6

-

3.6

-

-

3.6

68.1 (16.3)

(11.1) 1.8

57.0 (14.5)

(0.7) 0.2

(1.0) 0.3

55.3 (14.0)

51.8

(9.3)

42.5

(0.5)

(0.7)

41.3

Revenues Cost of revenues

Profit before tax Tax Profit for the period Earnings per share (assuming dilution) Shares outstanding (millions) Earnings per share – pence

1,395.9 3.71

1,395.9 3.05

1,395.9 2.96

ADSs outstanding (millions) Earnings per ADS – cents

465.3 17.96

465.3 14.75

465.3 14.35

14 of 18

(5.14) Normalised income statement for Q3 2011

Sharebased payments

Normalised incl sharebased payments

Intangible amortisation

Acquisition -related charges

IFRS

£m

£m

£m

£m

£m

£m

120.2

-

120.2

-

-

120.2

(6.1)

(0.8)

(6.9)

-

-

(6.9)

Gross profit

114.1

(0.8)

113.3

-

-

113.3

Research and development Sales and marketing General and administrative Total operating expenses

(29.8) (15.5) (15.2) (60.5)

(7.0) (2.3) (1.6) (10.9)

(36.8) (17.8) (16.8) (71.4)

(0.6) (0.1) (0.7)

(0.1) (0.2) (0.3)

(37.4) (18.0) (17.0) (72.4)

Profit from operations

53.6

(11.7)

41.9

(0.7)

(0.3)

40.9

Investment income, net

2.1

-

2.1

-

-

2.1

55.7 (13.8)

(11.7) 2.0

44.0 (11.8)

(0.7) 0.1

(0.3) 0.1

43.0 (11.6)

41.9

(9.7)

32.2

(0.6)

(0.2)

31.4

Normalised

Revenues Cost of revenues

Profit before tax Tax Profit for the period Earnings per share (assuming dilution) Shares outstanding (millions) Earnings per share – pence

1,376.0 3.05

1,376.0 2.35

1,376.0 2.29

ADSs outstanding (millions) Earnings per ADS – cents

458.7 14.24

458.7 10.97

458.7 10.68

15 of 18

(5.15) Normalised income statement for 9M 2012

Sharebased payments

Normalised incl sharebased payments

Intangible amortisation

Acquisitionrelated charges

Profit on sale of investment, net of impairment

IFRS

£m

£m

£m

£m

£m

£m

£m

Revenues

412.7

-

412.7

-

-

-

412.7

Cost of revenues

(21.9)

(1.4)

(23.3)

-

-

-

(23.3)

Gross profit

390.8

(1.4)

389.4

-

-

-

389.4

(97.2) (45.9) (61.3) (204.4)

(17.6) (5.1) (5.1) (27.8)

(114.8) (51.0) (66.4) (232.2)

(1.7) (0.4) (2.1)

(3.5) (0.3) (0.5) (4.3)

0.6 0.6

(120.0) (51.7) (66.3) (238.0)

Profit from operations

186.4

(29.2)

157.2

(2.1)

(4.3)

0.6

151.4

Investment income, net

10.2

-

10.2

-

-

10.2

Profit before tax Tax

196.6 (48.4)

(29.2) 2.8

167.4 (45.6)

(2.1) 0.7

(4.3) 1.4

0.6 0.2

161.6 (43.3)

Profit for the period

148.2

(26.4)

121.8

(1.4)

(2.9)

0.8

118.3

Normalised

Research and development Sales and marketing General and administrative Total operating expenses

Earnings per share (assuming dilution) Shares outstanding (millions) Earnings per share – pence

1,393.6 10.63

1,393.6 8.74

1,393.6 8.48

ADSs outstanding (millions) Earnings per ADS – cents

464.5 51.51

464.5 42.32

464.5 41.10

16 of 18

(5.16) Normalised income statement for 9M 2011

Sharebased payments

Normalised incl sharebased payments

Intangible amortisation

Acquisition -related charges

Linaro related charges

IFRS

£m

£m

£m

£m

£m

£m

£m

Revenues

354.0

-

354.0

-

-

-

354.0

Cost of revenues

(18.6)

(2.5)

(21.1)

-

-

-

(21.1)

Gross profit

335.4

(2.5)

332.9

-

-

-

332.9

(87.4) (43.2) (49.5) (180.1)

(26.3) (8.6) (6.2) (41.1)

(113.7) (51.8) (55.7) (221.2)

(1.8) (0.3) (2.1)

(0.3) (0.5) (0.8)

(6.9) (6.9)

(122.4) (52.4) (56.2) (231.0)

Profit from operations

155.3

(43.6)

111.7

(2.1)

(0.8)

(6.9)

101.9

Investment income, net

5.4

-

5.4

-

-

-

5.4

Profit before tax Tax

160.7 (40.5)

(43.6) 10.3

117.1 (30.2)

(2.1) 0.5

(0.8) 0.2

(6.9) 1.8

107.3 (27.7)

Profit for the period

120.2

(33.3)

86.9

(1.6)

(0.6)

(5.1)

79.6

Normalised

Research and development Sales and marketing General and administrative Total operating expenses

Earnings per share (assuming dilution) Shares outstanding (millions) Earnings per share – pence

1,374.2 8.75

1,374.2 6.32

1,374.2 5.79

ADSs outstanding (millions) Earnings per ADS – cents

458.1 40.88

458.1 29.55

458.1 27.06

17 of 18

Notes The results shown for Q3 2012, Q2 2012, Q3 2011, 9M 2012, and 9M 2011 are unaudited. The results shown for FY 2011 are audited. The consolidated financial information contained in this announcement does not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts of the Company in respect of the financial year ended 31 December 2011 were approved by the Board of directors on 27 February 2012 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified and did not contain an emphasis of matter paragraph nor any statement under Section 498 of the Companies Act 2006. The results for ARM for Q3 2012 and previous quarters as shown reflect the accounting policies as stated in Note 1 to the financial statements in the Annual Report and Accounts filed with Companies House in the UK for the fiscal year ended 31 December 2011 and in the Annual Report on Form 20-F for the fiscal year ended 31 December 2011. This document contains forward-looking statements as defined in section 102 of the Private Securities Litigation Reform Act of 1995. These statements are subject to risk factors associated with the semiconductor and intellectual property businesses. When used in this document, the words “anticipates”, “may”, “can”, “believes”, “expects”, “projects”, “intends”, “likely”, similar expressions and any other statements that are not historical facts, in each case as they relate to ARM, its management or its businesses and financial performance and condition are intended to identify those assertions as forward-looking statements. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables, many of which are beyond our control. These variables could cause actual results or trends to differ materially and include, but are not limited to: failure to realize the benefits of acquisitions, unforeseen liabilities arising from acquisitions, price fluctuations, actual demand, the availability of software and operating systems compatible with our intellectual property, the continued demand for products including ARM’s intellectual property, delays in the design process or delays in a customer’s project that uses ARM’s technology, the success of our semiconductor partners, loss of market and industry competition, exchange and currency fluctuations, any future strategic investments or acquisitions, rapid technological change, regulatory developments, ARM’s ability to negotiate, structure, monitor and enforce agreements for the determination and payment of royalties, actual or potential litigation, changes in tax laws, interest rates and access to capital markets, political, economic and financial market conditions in various countries and regions and capital expenditure requirements. More information about potential factors that could affect ARM’s business and financial results is included in ARM’s Annual Report on Form 20-F for the fiscal year ended 31 December 2011 including (without limitation) under the captions, “Risk Factors”(on pages 4 to 11) which is on file with the Securities and Exchange Commission (the “SEC”) and available at the SEC’s website at www.sec.gov. About ARM ARM designs the technology that lies at the heart of advanced digital products, from wireless, networking and consumer entertainment solutions to imaging, automotive, security and storage devices. ARM’s comprehensive product offering includes 32-bit RISC microprocessors, graphics processors, video engines, enabling software, cell libraries, embedded memories, high-speed connectivity products, peripherals and development tools. Combined with comprehensive design services, training, support and maintenance, and the company’s broad Partner community, they provide a total system solution that offers a fast, reliable path to market for leading electronics companies. More information on ARM is available at http://www.arm.com. ARM is a registered trademark of ARM Limited. ARM7, ARM9, ARM11, Cortex and Mali are trademarks of ARM Limited. All other brands or product names are the property of their respective holders. “ARM” is used to represent ARM Holdings plc; its operating company ARM Limited; and the regional subsidiaries: ARM Inc.; ARM KK; ARM Korea Ltd.; ARM Taiwan Limited; ARM France SAS; ARM Consulting (Shanghai) Co. Ltd.; ARM Belgium Services BVBA; ARM Germany GmbH; ARM Embedded Technologies Pvt. Ltd.; ARM Norway AS; and ARM Sweden AB.

18 of 18